Supreme Court Issues Long-Awaited Decisions in Oil States

New Post Public Reply Private Reply Replies (0) Message Board
CyberC gimli #29236
679
Supreme Court Issues Long-Awaited Decisions in Oil States and SAS Institute
April 24, 2018
Practices: Intellectual Property, Patent Trial & Appeal Board (PTAB) Proceedings
Printer-Friendly Version

On April 24, 2018, the U.S. Supreme Court handed down two decisions that have a significant impact on inter partes review proceedings before the Patent Trial and Appeal Board (“PTAB”) of the U.S. Patent and Trademark Office (“USPTO”). These proceedings review the patentability of patent claims previously issued by the USPTO.

The Court in Oil States Energy Services v. Greene’s Energy Group (decision here) found that these proceedings do not violate Article III or the Seventh Amendment because patents are public rights for purposes of this question. The Court in SAS Institute v. Iancu (decision here) found that the PTAB’s past practice of instituting review of fewer than all challenged claims violated the plain language of 35 U.S.C. § 318(a), which requires the PTAB to decide the patentability of all claims challenged in a petition.

Neither decision was unanimous, reflecting a rare divide among the Court in addressing patent issues. In Oil States, a 7-2 decision, Justice Thomas wrote for the majority; Justice Breyer wrote a concurring opinion joined by Justices Ginsburg and Sotomayor; and Justice Gorsuch wrote a dissent joined by Chief Justice Roberts. In SAS, a 5-4 decision, Justice Gorsuch wrote for the majority; Justice Ginsburg wrote a dissent joined by Justices Breyer, Sotomayor, and Kagan; and Justice Breyer also wrote a dissent joined by Justices Ginsburg and Sotomayor, and Justice Kagan in part.

Oil States: Inter Partes Review Trial Proceedings Are Constitutional Under Article III and the Seventh Amendment
Oil States had been involved in a patent infringement suit against Greene’s Energy Group, who filed an IPR petition challenging claims of the asserted patent. Ultimately, the PTAB held that the claims were unpatentable. Oil States then appealed the decision to the Federal Circuit and eventually to the Supreme Court, arguing in part that the inter partes review proceedings were contrary to Article III and the Seventh Amendment of the U.S. Constitution.

At the Supreme Court, Oil States argued that Article III, which vests the “judicial power of the United States” in the courts, prohibits the PTAB—a non-Article III forum—to extinguish private property rights in an adversarial proceeding such as an IPR. Oil States also argued that the Seventh Amendment’s jury trial right prohibits the PTAB from deciding issues of patentability. Despite previously denying several other similar petitions for certiorari, the Supreme Court granted Oil States’ petition, agreeing to review the constitutional questions presented. After several months of briefing, oral argument took place on November 27, 2017. Fifty-seven (57) briefs amicus curiae were filed at the merits stage, showing the intense public interest in the Court’s decision. In addition, the U.S. government also submitted briefing to the Court, in which it argued for the constitutionality of inter partes review, and participated in the oral argument.

Today, after a nearly five-month wait, the Supreme Court issued its decision affirming the Federal Circuit and upholding the constitutionality of IPR proceedings. In writing for the Court, Justice Thomas explained that patents convey a specific type of right—a “public franchise”—and that the reevaluation of the patentability of claims by the USPTO involves an adjudication of public rights. As such, the Court found that IPRs are not an improper exercise of the judicial power under either Article III of the Constitution or a violation of the right to a jury trial under the Seventh Amendment.

The Court’s affirmance of the status quo in Oil States is therefore unlikely to lead to any changes at the PTAB. However, the Court did emphasize the narrowness of its decision, noting that it was not addressing any retroactive issues associated with PTAB proceedings and reaffirming prior holdings are property protected by other provisions of the Constitution, such as the Fifth Amendment. Thus, the door may be open for possible future constitutional challenges.

SAS Institute: Partial Institution of Petitions Is Not Authorized
Although Oil States has garnered more attention than SAS, which was argued the same day, the Court’s decision in SAS will have significant impact on PTAB proceedings going forward. Section 314(a) of Title 35 states that the USPTO Director may not institute review unless the Director determines that “there is a reasonable likelihood that the petitioner would prevail with respect to at least 1 of the claims challenged in the petition.” If review is instituted, Section 318(a) states that the USPTO Director “shall issue a final written decision with respect to the patentability of any patent claim challenged by the petitioner and any new claim added under section 316(d).” Despite this directive, the PTAB only instituted review and issued a final written decision on a subset of the claims that SAS initially challenged. The Federal Circuit affirmed the PTAB’s practice of so-called “partial institution,” holding that the final written decision need only address the claims under review post-institution. The Supreme Court, however, found that the language of the statute is clear—SAS was entitled to a final written decision addressing all of the claims it has challenged, reversing the Federal Circuit and remanding the case for further proceedings.

The situation in SAS is not uncommon. Among the 4,000+ decisions instituting review to date, the PTAB has generally instituted review—and subsequently issued final written decisions—only on the particular claims for which the petitioner has shown that there is a reasonable likelihood that it would prevail at institution. While the USPTO has not released specific statistics, and a majority of these decisions have instituted as to all challenged claims, a significant number of these decisions have instituted as to fewer than all challenged claims.

The Court’s decision today raises important questions and issues going forward. For example, the Federal Circuit and the PTAB will need to address the impact of SAS on proceedings already subject to partial institutions, both before and after a final written decision has issued. The PTAB may also adjust the role that institution decisions will play if these decisions cannot narrow the number of claims at issue, because final written decisions must address all challenged claims. For example, rather than issuing detailed institution decisions with substantive analysis regarding all challenged claims, the PTAB may instead choose to issue a simplified notice of institution containing minimal, if any, information useful to the parties. Relatedly, petitioners and patent owners litigating before the PTAB will need to adjust their respective strategies in light of SAS and any changes in the PTAB’s practices. For example, because the issuance of a final written decision as to a claim triggers estoppel provisions under Section 315(e), petitioners will need to assess the impact of SAS if all challenged claims will be subject to a final written decision if the proceeding is instituted regardless of the likelihood of success as to each claim. Conversely, patent owners will likely adjust pre-institution strategies to focus attacks on the broadest claims and abandon prior practices attempting to avoid institution as to fewer than all of the challenged claims.

Short of legislative action or additional regulatory workarounds that attempt to maintain more of the status quo, the decision in SAS will significantly alter practice before the PTAB going forward.

We will continue to monitor further developments regarding the impact of these decisions. If you have any questions about this Alert, please contact Scott McKeown, Gabrielle Higgins, James Davis or Matthew Rizzolo.

Zerify Inc (ZRFY) Stock Research Links

ZRFY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Atlas-SSI Expands Grip in Water Control Space

Updated Category News Views 214

Atlas-SSI Makes Waves with Linita Acquisition Here's the kind of news that makes an old market hound sit up and take notice. Atlas-SSI, the big cheese in North America for water management solutions, has gone and snagged Linita Design & Manufacturing. Why's this worth talking about? Linita isn't just any player—they've been crafting custom-engineered hydro-mechanical...

Continue Reading
Q32 Bio Eyes New Horizons with Bempikibart's Potentials

Updated Category News Views 54

Q32 Bio Steers Forward: New Insights from Chief Results Today's update isn't just another quarterly snooze-fest—it’s a nudge in a crucial direction for Q32 Bio (NASDAQ:QTTB). After a bold brush with the European Academy of Dermatology and Venereology (EADV) Congress 2026, the company laid out a plan and a half, showing its hand with bempikibart for alopecia areata...

Continue Reading
MY DR NOW Expands: Seven-Day Clinics Open Everywhere

Updated Category News Views 29

Breaking The Mold Of Traditional Medicine MY DR NOW isn't here to play by the age-old rules. They're slinging open the doors to their newest family medicine clinics and kicking the old Monday-to-Friday scheduling straight to the curb. Every single day of the week, from 8 a.m. to 8 p.m., patients in Sunnyvale and Tucson are getting a dose of healthcare that's all about...

Continue Reading
DarioHealth Taps Palumbo to Drive Healthcare Evolution

Updated Category News Views 64

Strategic Leadership for an Evolving Market Prepare your portfolios, folks. DarioHealth Corp. (NASDAQ:DRIO) is gearing up to ride a seismic shift in healthcare. John R. Palumbo's appointment as Chairman of the Board marks a bold move as Dario looks to dominate the new convergence of consumer-directed and payer-funded healthcare. This isn't just a change of guard; it's a...

Continue Reading
Hyundai Pushes Hydrogen Boundaries at 2026 Expo

Updated Category News Views 105

A Bold Step Into the Hydrogen Era Hyundai's really stepping it up at the World Hydrogen Expo 2026. They're not just dipping their toes in the hydrogen pool—they're diving in headfirst, showing off integrated hydrogen solutions that are nothing short of ambitious. Hydrogen Production That's a Real Game Changer This ain't just talk. Hyundai's showcasing modular PEM...

Continue Reading
Greasezilla to Process 15M Gallons of FOG Yearly

Updated Category News Views 37

Greasezilla Steps Up for FOG Processing If there’s one thing that makes dealing with wastewater a greasy business, it’s FOG - fats, oils, and grease. It’s the stuff nightmares are made of for any utility trying to keep their pipes clear and their operations running smooth. Now, Greasezilla is stepping into the spotlight at one of the country's largest wastewater...

Continue Reading
Natixis' $100M Student Challenge Mixes Real Stakes

Updated Category News Views 100

Opportunity Knocks for Budding Portfolio Managers Picture this: You're a student, neck-deep in textbooks and theories, and then bam! You're handed the keys to manage a $100 million portfolio. That's the real-deal opportunity Natixis Investment Managers is dangling with its seventh Students Challenge. Diving Into the Nuts and Bolts Listen up, kids. Applications are open...

Continue Reading
Camtek Hits Record Q3 Revenue; Strong Growth Ahead

Updated Category News Views 99

Camtek's Record Performance in Q3 2026 Diving straight into the numbers, Camtek (NASDAQ:CAMT) just posted a staggering $161.3 million in Q3 2026 revenues, marking a 21% jump from the previous quarter. Now, that kind of growth isn't just impressive; it's a wake-up call to any investor still snoozing on semiconductor stocks. They're looking at revenues of around $180...

Continue Reading
Sinch Partners with SpaceX's Super Intelligence Network

Updated Category News Views 101

Piecing Together the New Sinch and SpaceX Partnership Here's a juicy piece of tech news that might just tickle those investing antennas: Sinch AB's teaming up with the SpaceX Super Intelligence Network as a Marketplace Partner. Let's rip the Band-Aid off about why this development has investors riled and buzzing with expectation. Now, Sinch might not be the first company...

Continue Reading
Askey & Icom Team Up: Trading Airwaves for Partnerships

Updated Category News Views 28

Old-School Radios Meet Cutting-Edge 5G When I hear about a company linking their old-school tech with shiny new 5G jazz, skepticism kicks in fast. But then comes this announcement: Askey and Icom America are joining forces to bring 5G networks with integrated two-way radio systems to various sectors—like a classic combo meal with a tech twist. The key audience? Utility...

Continue Reading

Top 5 Most Recently Viewed Articles

Akebia Develops Unique Kidney Disease Treatments for Patients

Updated Category News Views 198

Akebia's Commitment to Rare Kidney Disease Solutions In a significant advancement for the management of kidney diseases, Akebia Therapeutics, Inc. (Nasdaq: AKBA) has announced the formation of a rare kidney disease pipeline. This initiative highlights the company's sustained commitment to improve the lives of individuals affected by diverse kidney disorders. The pipeline...

Continue Reading
Enhancing Compliance: Coalfire and Vanta's Strategic Alliance

Updated Category News Views 129

Strengthening Compliance through Innovative Partnerships In an era of constant digital transformation, organizations face escalating challenges in maintaining compliance and optimizing security. The partnership between Coalfire and Vanta is strategically designed to revolutionize compliance processes, making them more efficient and less burdensome for internal teams....

Continue Reading
Free Health Screening Initiative for Heart and Kidney Risks

Updated Category News Views 181

Introducing the Heart and Kidney Health Screening Program In a significant step towards improving community health, Care Access is launching its Heart & Kidney Health Screening initiative. This program aims to raise awareness and provide essential health checks for various risk factors, particularly focusing on lipoprotein(a), commonly referred to as Lp(a). Research...

Continue Reading
Transense Technologies Director Increases Stake Significantly

Updated Category News Views 196

Director of Transense Technologies Boosts His Shareholding LONDON - Transense Technologies plc (AIM: TRT), a leading company in sensor solutions and measurement systems, has seen its Managing Director, Ryan Maughan, expand his shareholding. Recently, Maughan bought 3,025 ordinary shares at a price of 165 pence each, underscoring his confidence in the company's potential....

Continue Reading
Significant Insider Trading Alert: Century Aluminum's SVP Action

Updated Category News Views 203

Recent Insider Trading Activity at Century Aluminum Notable insider trading activity was reported recently surrounding Century Aluminum involving their Senior Vice President, Matt Aboud. The SEC filings revealed that Aboud sold an impressive 12,027 shares of the company. The total value of this transaction amounted to approximately $279,868. Market Response and Share...

Continue Reading